Burkitt Lymphoma in Uganda. A study of some biological and epidemiological aspects of endemic Burkitt lymphoma
Doctoral thesis
Permanent lenke
https://hdl.handle.net/1956/5012Utgivelsesdato
2011-08-25Metadata
Vis full innførselSamlinger
Består av
Paper I: East African Medical Journal 86(5), Kalungi, S.; Wabinga, H.; Molven, A.; Bostad, L., Lymphomas diagnosed in Uganda during the HIV/AIDS pandemic, pp. 226-232. Full text not available in BORA due to publisher restrictions.Paper II: APMIS 117(4), Kalungi, S.; Wabinga, H.; Bostad, L., Reactive lymphadenopathy in Ugandan patients and its relationship to EBV and HIV infection, pp. 302-307. Full text not available in BORA due to publisher restrictions. The article is available at: http://dx.doi.org/10.1111/j.1600-0463.2009.02444.x
Paper III: BMC Clinical Pathology 9(6), Kalungi, S.; Steine, S. J.; Wabinga, H.; Bostad, L.; Molven, A., pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda. The article is available at: http://hdl.handle.net/1956/5011
Paper IV: Journal of Pediatric Hematology/Oncology 33(2), Kalungi, S.; Wabinga, H.; Bostad, L., The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma, e54–e59. Full text not available in BORA due to publisher restrictions. The article is available at: http://dx.doi.org/10.1097/MPH.0b013e3181edf543
Paper V: Kalungi, S.; Wabinga, H.; Bostad, L., 2011, Expression of apoptosis associated proteins SURVIVIN, LIVIN and THROMBOSPONDIN-1 in Burkitt lymphoma. Full text not available in BORA.
Utgiver
The University of BergenOpphavsrett
Copyright the author. All rights reservedThe author